TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Obagi Medical Products, Inc. (NASDAQ:OMPI) Investor Investigation Over Buyout Bid By Valeant Pharmaceuticals International Announced

  • If you purchased shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) prior to March 20, 2013, and currently hold any of those NASDAQ:OMPI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Mar. 20, 2013 (Shareholders Foundation) - An investigation on behalf of investors in Obagi Medical Products, Inc. (NASDAQ:OMPI) shares was announced concerning whether the offer by Valeant Pharmaceuticals International to acquire Obagi Medical Products, Inc. for $19.75 per NASDAQ:OMPI share and the takeover process are unfair to investors in Obagi Medical Products shares. The investi...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: